Jade Biosciences, Inc. (JBIO)

Jade Biosciences, Inc. (JBIO) is a healthcare company (biotechnology) based in the United States. The share price is $15.40, up 0.42% on the day, which values the company at $1.07B. Price as of 17 Nov 2026, 21:41 UTC, from Yahoo Finance.

Key facts

Share price
$15.40+0.42% today
Market value
$1.07B
200-week average
$267.0394% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Jade Biosciences, Inc. in more detail

JBIO trades at -6.8× next year's expected earnings. It sits 94% below its 200-week average of $267.03.

In its favour: More cash than debt.

2 of the superinvestors tracked here hold JBIO, including Peter Kolchinsky (0.7% of the portfolio), Julian and Felix Baker (0.1% of the portfolio).

Superinvestors holding JBIO

2 of the investors tracked here report a position in their latest 13F filing.

Jade Biosciences, Inc. (JBIO): questions and answers

What is Jade Biosciences, Inc.'s market cap?

Jade Biosciences, Inc. is valued at $1.07B at a share price of $15.40.

Is JBIO above its 200-week moving average?

No. JBIO is 94.2% below its 200-week average of $267.03. Long-term investors watch that line because strong companies rarely trade below it for long.

Does JBIO pay a dividend?

Jade Biosciences, Inc. does not currently pay a regular dividend.

Which famous investors own JBIO?

In their latest quarterly filings, Peter Kolchinsky (0.7% of the portfolio), Julian and Felix Baker (0.1% of the portfolio) hold JBIO. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

Cite this page

Funkfolio, “Jade Biosciences, Inc. (JBIO) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/JBIO

Underlying data: Yahoo Finance; company filings with the SEC.